| 1 |
34780725 | Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy. | 2022 Jan 1 |
3 |
| 2 |
33932130 | Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate). | 2021 Sep |
1 |
| 3 |
30094711 | Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib. | 2019 Apr |
3 |
| 4 |
29574693 | Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure. | 2018 Dec |
1 |
| 5 |
25449654 | Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib. | 2015 Apr |
1 |
| 6 |
24748562 | The metabolic drug-drug interaction profile of Dabrafenib: in vitro investigations and quantitative extrapolation of the P450-mediated DDI risk. | 2014 Jul |
3 |